Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 6/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | PRCP | P42785 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1612406 | 0.85 | HDAC4 (0.47) | OPRM1OPRK1SLC6A4MEN1KMT2A | |
| SCHEMBL27296884 | 0.83 | HDAC4 (0.46) | OPRM1OPRK1SLC6A4MEN1KMT2A | |
| SCHEMBL5690461 | 0.81 | HDAC4 (0.37) | OPRM1SLC6A4SLC22A1SMN1; SMN2MEN1 | |
| SCHEMBL28279427 | 0.80 | OPRM1 (0.41) | OPRM1OPRD1OPRK1SLC6A4SLC22A1 | |
| SCHEMBL5690328 | 0.79 | HDAC4 (0.36) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL1904196 | 0.79 | CHRM2 (0.50) | OPRM1SLC22A1ADRA1AKCNH2SMN1; SMN2 | |
| SCHEMBL290754 | 0.79 | HDAC4 (0.50) | SLC6A4SMN1; SMN2MEN1KMT2AHDAC4 | |
| SCHEMBL27774530 | 0.79 | HDAC4 (0.50) | SLC6A4SMN1; SMN2MEN1KMT2AHDAC4 | |
| SCHEMBL19357459 | 0.79 | SMN1; SMN2 (0.45) | OPRM1OPRD1OPRK1SLC6A4SLC22A1 | |
| SCHEMBL1953126 | 0.77 | AKR1C1 (0.50) | SLC6A4SMN1; SMN2MEN1KMT2AHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10449173-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | ALLERGAN SALES, LLC (US) | 2019-10-22 | — | — | US | claimed |
| EP-3287122-B1 | DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS FOR TREATING OVERACTIVE BLADDERS. | ALLERGAN SALES LLC (US) | 2019-04-17 | — | — | EP | claimed |
| EP-3287122-A1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Allergan Sales, LLC (US) | 2018-02-28 | — | — | EP | claimed |
| EP-2427172-B1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | ALLERGAN SALES LLC (US) | 2017-11-01 | — | — | EP | claimed |
| US-20160128963-A1 | METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | WATSON LABORATORIES, INC. | 2016-05-12 | — | — | US | claimed |
| US-9259388-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | WATSON PHARMACEUTICALS, INC. (US) | 2016-02-16 | — | — | US | claimed |
| US-8920392-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | WATSON LABORATORIES, INC. (US) | 2014-12-30 | — | — | US | claimed |
| US-20140046275-A1 | Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions | WATSON LABORATORIES, INC. (US) | 2014-02-13 | — | — | US | claimed |
| EP-2427172-A2 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Watson Laboratories, Inc. (US) | 2012-03-14 | — | — | EP | claimed |
| WO-2010129498-A2 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | WATSON LABORATORIES, INC. (US) | 2010-11-11 | — | — | WO | claimed |
| US-20100286630-A1 | Method For Treating Overactive Bladders And A Device For Storage And Administration Of Topical Oxybutynin Compositions | WATSON LABORATORIES, INC. (US) | 2010-11-11 | — | — | US | claimed |
| US-10449173-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | ALLERGAN SALES, LLC (US) | 2019-10-22 | — | — | US | disclosed |
| EP-3287122-B1 | DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS FOR TREATING OVERACTIVE BLADDERS. | ALLERGAN SALES LLC (US) | 2019-04-17 | — | — | EP | disclosed |
| EP-3287122-A1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Allergan Sales, LLC (US) | 2018-02-28 | — | — | EP | disclosed |
| EP-2427172-B1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | ALLERGAN SALES LLC (US) | 2017-11-01 | — | — | EP | disclosed |
| US-20140046275-A1 | Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions | WATSON LABORATORIES, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| EP-2427172-A2 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Watson Laboratories, Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
| WO-2010129498-A2 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | WATSON LABORATORIES, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| US-20100286630-A1 | Method For Treating Overactive Bladders And A Device For Storage And Administration Of Topical Oxybutynin Compositions | WATSON LABORATORIES, INC. (US) | 2010-11-11 | — | — | US | disclosed |
| CN-1558756-A | Pharmaceutical compositions for the treatment of urinary disorders | �ź㴫 | 2004-12-29 | — | — | CN | disclosed |